Aspergillosis Treatment Market Opportunity Analysis, 2018-2026
Aspergillosis is a group of diseases that occur from aspergillus infection. Aspergillus is a fungus whose spores are present in the air, but does not normally cause illness. Individuals with damaged lungs, sensitive immune system, and allergies are more prone to Aspergillus induced infection. Common Aspergillus infections include invasive Aspergillosis, non-invasive Allergic Pulmonary Aspergillosis (ABPA), and Chronic Pulmonary and Aspergilloma (CPA). Invasive aspergillosis is uncommon and occurs primarily in immunocompromised people.
Aspergillosis is a group of diseases that occur from aspergillus infection. Aspergillus is a fungus whose spores are present in the air, but does not normally cause illness. Individuals with damaged lungs, sensitive immune system, and allergies are more prone to Aspergillus induced infection. Common Aspergillus infections include invasive Aspergillosis, non-invasive Allergic Pulmonary Aspergillosis (ABPA), and Chronic Pulmonary and Aspergilloma (CPA). Invasive aspergillosis is uncommon and occurs primarily in immunocompromised people.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Aspergillosis</strong> <strong>Treatment</strong> <strong>Market</strong><br />
GLOBAL INDUSTRY INSIGHTS, TRENDS,<br />
OUTLOOK, AND OPPORTUNITY ANALYSIS, <strong>2018</strong>-<br />
<strong>2026</strong><br />
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION<br />
<strong>Aspergillosis</strong> <strong>Treatment</strong> <strong>Market</strong> – Overview<br />
<strong>Aspergillosis</strong> is a group of diseases that occur from aspergillus infection. Aspergillus is a fungus whose spores are present in the air,<br />
but does not normally cause illness. Individuals with damaged lungs, sensitive immune system, and allergies are more prone to<br />
Aspergillus induced infection. Common Aspergillus infections include invasive <strong>Aspergillosis</strong>, non-invasive Allergic Pulmonary<br />
<strong>Aspergillosis</strong> (ABPA), and Chronic Pulmonary and Aspergilloma (CPA). Invasive aspergillosis is uncommon and occurs primarily<br />
in immunocompromised people. Chronic pulmonary aspergillosis is rare pulmonary disease, which increases symptoms of<br />
respiratory disorders such as asthma. According to a study published by European Respiratory Society (ERS) publications, in 2015,<br />
CPA is estimated to affect nearly 240,000 people in Europe. The most common form of CPA is Chronic Cavitary Pulmonary<br />
<strong>Aspergillosis</strong> (CCPA), which if left untreated can develop chronic fibrosing pulmonary aspergillosis. According to a statistics<br />
published by Centers for Disease Control and prevention, (CDC) an estimated 10% of individuals with asthma or cystic fibrosis<br />
experience an allergic reaction to aspergillus. ABPA is estimated to affect 2-15% of patients with cystic fibrosis and around 2% of<br />
all asthma patients.<br />
Increasing prevalence of <strong>Aspergillosis</strong> and favorable government regulations are the major factors driving growth of the<br />
<strong>Aspergillosis</strong> treatment market. According to a study published in Journal of Fungi 2016, CPA is estimated to affect nearly three<br />
million people globally making it major health problem resulting in mortality and morbidity. <strong>Aspergillosis</strong> infection can be treated<br />
with antifungal and corticosteroids drugs. Corticosteroid drugs are prescribed for allergic bronchopulmonary aspergillosis treatment.<br />
Click To Continue Reading on <strong>Aspergillosis</strong> <strong>Treatment</strong> <strong>Market</strong><br />
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION<br />
<strong>Aspergillosis</strong> <strong>Treatment</strong> <strong>Market</strong> Taxonomy:<br />
On the basis of drugs class, the aspergillosis treatment market is segmented into:<br />
Corticosteroids<br />
Anti-fungal<br />
On the basis of disease type, the aspergillosis treatment market is segmented into:<br />
Invasive <strong>Aspergillosis</strong><br />
Chronic Pulmonary <strong>Aspergillosis</strong><br />
Allergic Bronchopulmonary <strong>Aspergillosis</strong><br />
Allergic Aspergillus Sinusitis<br />
Aspergilloma<br />
Cutaneous <strong>Aspergillosis</strong><br />
Request Sample Copy of this Business Report @<br />
https://www.coherentmarketinsights.com/insight/request-sample/1587<br />
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION<br />
<strong>Aspergillosis</strong> <strong>Treatment</strong> <strong>Market</strong>: Key Players<br />
Major players involved in the global aspergillosis treatment market include:<br />
●<br />
Abbott laboratories<br />
●<br />
AstraZeneca plc<br />
●<br />
Eli Lilly and Company<br />
●<br />
GlaxoSmithKline<br />
●<br />
Johnson & Johnson Services, Inc.<br />
●<br />
Mylan Pharmaceuticals, Inc.<br />
●<br />
Novartis AG, Pfizer, Inc.<br />
●<br />
Takeda Pharmaceutical Company Ltd.<br />
Access Table of Content (TOC) Of the Report:<br />
https://www.coherentmarketinsights.com/ongoing-insight/toc/1587<br />
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS<br />
ABOUT US<br />
Coherent <strong>Market</strong> Insights is a global market intelligence and consulting<br />
organization focused on assisting its plethora of clients achieve transformational<br />
growth by helping them make critical business decisions. We are headquartered in<br />
India, with an office at the global financial capital in the U.S. Our client base<br />
includes players from across all business verticals in over 150 countries worldwide.<br />
We are uniquely positioned to help businesses around the globe deliver practical<br />
and lasting results through various recommendations about operational<br />
improvements, technologies, emerging market trends and new working methods.<br />
We offer both customized and syndicated market research reports that help our<br />
clients create visionary growth plans to provide traction to their business. We<br />
meticulously study emerging trends across various industries at both the global<br />
and regional levels to identify new opportunities for our clientele.<br />
SERVICES<br />
INDUSTRY ANALYSIS<br />
MARKET INTELLIGENCE<br />
SERVICES<br />
CUSTOMIZED<br />
RESEARCH<br />
CONSULT STUDIES<br />
SYNDICATED RESEARCH<br />
COUNTRY SPECIFIC<br />
STUDIES<br />
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS<br />
Industries we cater<br />
SECTOR COVERAGE<br />
Healthcare<br />
BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT<br />
MEDICAL DEVICES<br />
MEDICAL IMAGING<br />
Chemicals & Materials<br />
PHARMACEUTICAL<br />
Bulk Chemicals Advanced Materials Speciality and Fine<br />
Chemicals<br />
Green Chemicals<br />
Food Ingredients<br />
Cosmetic<br />
Ingredients<br />
Polymers &<br />
Resins<br />
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS<br />
KEY STATS<br />
100+<br />
Insights Published Per Year<br />
150+<br />
Consulting Projects Till Date<br />
125+<br />
Clients Worldwide Per Year<br />
RESEARCH SOLUTIONS<br />
CONSULT<br />
PROJECTS<br />
SURVEY<br />
RESEAR<br />
CH<br />
FEASIBILITY<br />
STUDIES<br />
EXCEL<br />
FORECAST<br />
DATABASE<br />
GLOBAL<br />
REPORTS<br />
COUNTRY<br />
ANALYSIS<br />
CUSTOMIZED<br />
SOLUTIONS<br />
COMPETITIVE<br />
ASSESSMENT<br />
110+<br />
Analysts and Contract Consultants<br />
TECHNOLOGY<br />
SNIPPETS<br />
Coherent <strong>Market</strong> Insights excels at offering unmatched actionable market intelligence across various industry verticals, including<br />
chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in<br />
the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various<br />
industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely<br />
designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed<br />
markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.<br />
© Coherent market Insights. All Rights Reserved
THANK YOU<br />
To know more about us, visit our website:<br />
www.coherentmarketinsights.com<br />
For sales queries or new topics email us on:<br />
sales@coherentmarketinsights.com<br />
For other queries contact:<br />
Mr. Shah<br />
(Manager - Business Development)<br />
Coherent <strong>Market</strong> Insights<br />
sales@coherentmarketinsights.com<br />
+1-206-701-6702<br />
© Coherent market Insights. All Rights Reserved
Change language